294 related articles for article (PubMed ID: 11525169)
1. Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody.
Karpusas M; Lucci J; Ferrant J; Benjamin C; Taylor FR; Strauch K; Garber E; Hsu YM
Structure; 2001 Apr; 9(4):321-9. PubMed ID: 11525169
[TBL] [Abstract][Full Text] [Related]
2. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
3. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
[TBL] [Abstract][Full Text] [Related]
4. 2 A crystal structure of an extracellular fragment of human CD40 ligand.
Karpusas M; Hsu YM; Wang JH; Thompson J; Lederman S; Chess L; Thomas D
Structure; 1995 Oct; 3(10):1031-9. PubMed ID: 8589998
[TBL] [Abstract][Full Text] [Related]
5. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
Monaco-Malbet S; Berthet-Colominas C; Novelli A; Battaï N; Piga N; Cheynet V; Mallet F; Cusack S
Structure; 2000 Oct; 8(10):1069-77. PubMed ID: 11080628
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
7. CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.
Shock A; Burkly L; Wakefield I; Peters C; Garber E; Ferrant J; Taylor FR; Su L; Hsu YM; Hutto D; Amirkhosravi A; Meyer T; Francis J; Malcolm S; Robinson M; Brown D; Shaw S; Foulkes R; Lawson A; Harari O; Bourne T; Maloney A; Weir N
Arthritis Res Ther; 2015 Sep; 17(1):234. PubMed ID: 26335795
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumab.
Asano R; Nakakido M; Pérez JF; Ise T; Caaveiro JMM; Nagata S; Tsumoto K
Biochem Biophys Res Commun; 2024 Jun; 714():149969. PubMed ID: 38657446
[TBL] [Abstract][Full Text] [Related]
9. The role of polar interactions in the molecular recognition of CD40L with its receptor CD40.
Singh J; Garber E; Van Vlijmen H; Karpusas M; Hsu YM; Zheng Z; Naismith JH; Thomas D
Protein Sci; 1998 May; 7(5):1124-35. PubMed ID: 9605317
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the 64M-2 antibody Fab fragment in complex with a DNA dT(6-4)T photoproduct formed by ultraviolet radiation.
Yokoyama H; Mizutani R; Satow Y; Komatsu Y; Ohtsuka E; Nikaido O
J Mol Biol; 2000 Jun; 299(3):711-23. PubMed ID: 10835279
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD40 antibody 2C10 binds to a conformational epitope at the CD40-CD154 interface that is conserved among primate species.
Michaels AJ; Stoppato M; Flores WJ; Reimann KA; Engelman KD
Am J Transplant; 2020 Jan; 20(1):298-305. PubMed ID: 31430418
[TBL] [Abstract][Full Text] [Related]
13. CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling.
Léveillé C; Bouillon M; Guo W; Bolduc J; Sharif-Askari E; El-Fakhry Y; Reyes-Moreno C; Lapointe R; Merhi Y; Wilkins JA; Mourad W
J Biol Chem; 2007 Feb; 282(8):5143-51. PubMed ID: 17182621
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
17. Structure and specificity of the anti-digoxin antibody 40-50.
Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
[TBL] [Abstract][Full Text] [Related]
18. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
[TBL] [Abstract][Full Text] [Related]
19. CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches.
Argiriadi MA; Benatuil L; Dubrovska I; Egan DA; Gao L; Greischar A; Hardman J; Harlan J; Iyer RB; Judge RA; Lake M; Perron DC; Sadhukhan R; Sielaff B; Sousa S; Wang R; McRae BL
BMC Mol Cell Biol; 2019 Aug; 20(1):29. PubMed ID: 31382872
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the HIV-2 neutralizing Fab fragment 7C8 with high specificity to the V3 region of gp125.
Uchtenhagen H; Friemann R; Raszewski G; Spetz AL; Nilsson L; Achour A
PLoS One; 2011 Apr; 6(4):e18767. PubMed ID: 21541316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
